Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
PLoS Pathog ; 8(3): e1002579, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22438807

RESUMO

Heme oxygenase 1 (HO-1) is an essential enzyme induced by heme and multiple stimuli associated with critical illness. In humans, polymorphisms in the HMOX1 gene promoter may influence the magnitude of HO-1 expression. In many diseases including murine malaria, HO-1 induction produces protective anti-inflammatory effects, but observations from patients suggest these may be limited to a narrow range of HO-1 induction, prompting us to investigate the role of HO-1 in malaria infection. In 307 Gambian children with either severe or uncomplicated P. falciparum malaria, we characterized the associations of HMOX1 promoter polymorphisms, HMOX1 mRNA inducibility, HO-1 protein levels in leucocytes (flow cytometry), and plasma (ELISA) with disease severity. The (GT)(n) repeat polymorphism in the HMOX1 promoter was associated with HMOX1 mRNA expression in white blood cells in vitro, and with severe disease and death, while high HO-1 levels were associated with severe disease. Neutrophils were the main HO-1-expressing cells in peripheral blood, and HMOX1 mRNA expression was upregulated by heme-moieties of lysed erythrocytes. We provide mechanistic evidence that induction of HMOX1 expression in neutrophils potentiates the respiratory burst, and propose this may be part of the causal pathway explaining the association between short (GT)(n) repeats and increased disease severity in malaria and other critical illnesses. Our findings suggest a genetic predisposition to higher levels of HO-1 is associated with severe illness, and enhances the neutrophil burst leading to oxidative damage of endothelial cells. These add important information to the discussion about possible therapeutic manipulation of HO-1 in critically ill patients.


Assuntos
Expressão Gênica , Predisposição Genética para Doença , Heme Oxigenase-1/genética , Malária Falciparum/sangue , Regiões Promotoras Genéticas , Criança , Pré-Escolar , Feminino , Gâmbia/epidemiologia , Frequência do Gene , Heme Oxigenase-1/sangue , Humanos , Leucócitos/metabolismo , Malária Falciparum/diagnóstico , Malária Falciparum/mortalidade , Masculino , Neutrófilos/metabolismo , Polimorfismo Genético , RNA Mensageiro/metabolismo , Explosão Respiratória , Taxa de Sobrevida
2.
J Clin Immunol ; 33(8): 1386-94, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24036839

RESUMO

PURPOSE: Vitamin A metabolites, such as all-trans-retinoic acid (RA) that act through the nuclear receptor; retinoic acid receptor (RAR), have been shown to polarise T cells towards Th2, and to be important in resistance to helminth infections. Co-incidentally, people harbouring intestinal parasites are often supplemented with vitamin A, as both vitamin A deficiency and parasite infections often occur in the same regions of the globe. However, the impact of vitamin A supplementation on gut inflammation caused by intestinal parasites is not yet completely understood. METHODS: Here, we use Trichuris muris, a helminth parasite that buries into the large intestine of mice causing mucosal inflammation, as a model of both human trichuriasis and IBD, treat with an RARα/ß agonist (Am80) and quantify the ensuing pathological changes in the gut. RESULTS: Critically, we show, for the first time, that rather than playing an anti-inflammatory role, Am80 actually exacerbates helminth-driven inflammation, demonstrated by an increased colonic crypt length and a significant CD4(+) T cell infiltrate. Further, we established that the Am80-driven crypt hyperplasia and CD4(+) T cell infiltrate were dependent on IL-6, as both were absent in Am80-treated IL-6 knock-out mice. CONCLUSIONS: This study presents novel data showing a pro-inflammatory role of RAR ligands in T. muris infection, and implies an undesirable effect for the administration of vitamin A during chronic helminth infection.


Assuntos
Benzoatos/farmacologia , Mediadores da Inflamação/farmacologia , Interleucina-6/fisiologia , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/imunologia , Tetra-Hidronaftalenos/farmacologia , Tricuríase/imunologia , Tricuríase/metabolismo , Regulação para Cima/efeitos dos fármacos , Animais , Células Cultivadas , Quimiotaxia de Leucócito/efeitos dos fármacos , Quimiotaxia de Leucócito/imunologia , Doença Crônica , Modelos Animais de Doenças , Interleucina-6/deficiência , Mucosa Intestinal/patologia , Masculino , Camundongos , Camundongos Endogâmicos AKR , Camundongos Endogâmicos C57BL , Camundongos Knockout , Receptores do Ácido Retinoico/agonistas , Tricuríase/patologia , Trichuris/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA